RAS mutations affect pattern of metastatic spread and increase propensity for brain metastasis in colorectal cancer Journal Article


Authors: Yaeger, R.; Cowell, E.; Chou, J. F.; Gewirtz, A. N.; Borsu, L.; Vakiani, E.; Solit, D. B.; Rosen, N.; Capanu, M.; Ladanyi, M.; Kemeny, N.
Article Title: RAS mutations affect pattern of metastatic spread and increase propensity for brain metastasis in colorectal cancer
Abstract: BACKGROUND RAS and PIK3CA mutations in metastatic colorectal cancer (mCRC) have been associated with worse survival. We sought to evaluate the impact of RAS and PIK3CA mutations on cumulative incidence of metastasis to potentially curable sites of liver and lung and other sites such as bone and brain. METHODS We performed a computerized search of the electronic medical record of our institution for mCRC cases genotyped for RAS or PIK3CA mutations from 2008 to 2012. Cases were reviewed for patient characteristics, survival, and site-specific metastasis. RESULTS Among the 918 patients identified, 477 cases were RAS wild type, and 441 cases had a RAS mutation (394 at KRAS exon 2, 29 at KRAS exon 3 or 4, and 18 in NRAS). RAS mutation was significantly associated with shorter median overall survival (OS) and on multivariate analysis independently predicted worse OS (HR, 1.6; P < .01). RAS mutant mCRC exhibited a significantly higher cumulative incidence of lung, bone, and brain metastasis and on multivariate analysis was an independent predictor of involvement of these sites (HR, 1.5, 1.6, and 3.7, respectively). PIK3CA mutations occurred in 10% of the 786 cases genotyped, did not predict for worse survival, and did not exhibit a site-specific pattern of metastatic spread. CONCLUSIONS The metastatic potential of CRC varies with the presence of RAS mutation. RAS mutation is associated with worse OS and increased incidence of lung, bone, and brain metastasis. An understanding of this site-specific pattern of spread may help to inform physicians' assessment of symptoms in patients with mCRC. © 2014 American Cancer Society.
Keywords: adult; cancer survival; controlled study; middle aged; gene mutation; gene sequence; major clinical study; overall survival; bone metastasis; colorectal cancer; genetic association; genotype; gene frequency; mutational analysis; oncogene; electronic medical record; liver metastasis; lung metastasis; brain metastasis; neoplasm metastasis; oncogene k ras; pik3ca gene; oncogene ras; ras; oncogene n ras; metastatic colorectal cancer; pik3ca; survival prediction; prognosis; human; male; female; priority journal; article
Journal Title: Cancer
Volume: 121
Issue: 8
ISSN: 0008-543X
Publisher: Wiley Blackwell  
Date Published: 2015-04-15
Start Page: 1195
End Page: 1203
Language: English
DOI: 10.1002/cncr.29196
PROVIDER: scopus
PUBMED: 25491172
PMCID: PMC4523078
DOI/URL:
Notes: Export Date: 4 May 2015 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Joanne Fu-Lou Chou
    331 Chou
  2. Neal Rosen
    425 Rosen
  3. David Solit
    779 Solit
  4. Marinela Capanu
    385 Capanu
  5. Marc Ladanyi
    1326 Ladanyi
  6. Rona Denit Yaeger
    315 Yaeger
  7. Efsevia Vakiani
    263 Vakiani
  8. Nancy Kemeny
    543 Kemeny
  9. Alexandra Gewirtz
    21 Gewirtz
  10. Elizabeth Peale Cowell
    1 Cowell